Edoardo Bressi

Interleukin‐1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST‐Segment–Elevation Myocardial Infarction

Antonio Abbate, Cory R. Trankle, Leo F. Buckley et al. · Journal of the American Heart Association · 2020 · 281 citations · Full text

Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II–III Systolic Heart Failure

George F. Wohlford, Benjamín Van Tassell, Hayley Billingsley et al. · Journal of Cardiovascular Pharmacology · 2020 · 138 citations · Full text

Heart Failure, Cardiovascular Pharmacology, Pharmacotherapy +18

Interleukin-1β Blockade Improves Left Ventricular Systolic/Diastolic Function and Restores Contractility Reserve in Severe Ischemic Cardiomyopathy in the Mouse

Stefano Toldo, Eleonora Mezzaroma, Edoardo Bressi et al. · Journal of Cardiovascular Pharmacology · 2014 · 78 citations

The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The <scp>CANA‐HF</scp> study

Salvatore Carbone, Hayley Billingsley, Justin M. Canada et al. · Diabetes/Metabolism Research and Reviews · 2020 · 69 citations · Full text

Sarcopenic Obesity Is Associated With Reduced Cardiorespiratory Fitness Compared With Nonsarcopenic Obesity in Patients With Heart Failure With Reduced Ejection Fraction

Hayley Billingsley, Marco Giuseppe Del Buono, Justin M. Canada et al. · Circulation Heart Failure · 2022 · 42 citations · Full text